IL6 and cancer: Accordingly, ISG20 upregulation was associated with coagulation, epithelial-mesenchymal transition, angiogenesis, complement, and cancer/immune-related signaling, such as KRAS, PI3K-AKT-mTOR, and IL6-JAK-STAT3 (Fig. 5E).